AgingResearch.NewsJoin free

(n-ac-tyr1,d-arg2)ghrh-

Intervention

1 finding

“Graded infusions of GHRH antagonist suppressed GH responses to GHRH in a dose-dependent manner, but with similar potency in both groups.”
In vivo semiquantification of hypothalamic growth hormone-releasing hormone (GHRH) output in humans: evidence for relative GHRH deficiency in agingThe Journal of clinical endocrinology and metabolism1999doi:10.1210/jcem.84.10.6063

C, W, M, H: cells, worms or flies, mice, humans. Dark: independent labs found the same change there. Light: one lab or one study. Outline: nothing yet.

  • 1 lab

What did studies of (n-ac-tyr1,d-arg2)ghrh- find?

1

Studies of (n-ac-tyr1,d-arg2)ghrh- measured 1 outcome; the most studied are growth hormone secretion (1 study).

Growth hormone secretion

downin humans1

1 study

  1. (n-ac-tyr1,d-arg2)ghrh- decreases growth hormone secretion in humans.

    “Graded infusions of GHRH antagonist suppressed GH responses to GHRH in a dose-dependent manner, but with similar potency in both groups.”

    Human trialGHRH-stimulated secretion in healthy mengraded infusionsmales

    In vivo semiquantification of hypothalamic growth hormone-releasing hormone (GHRH) output in humans: evidence for relative GHRH deficiency in aging

    The Journal of clinical endocrinology and metabolism

More on Growth hormone secretion